The Changing Epidemiology of Desmoplastic Melanoma.

Tricia Tay, Martin G Cook, Kyoko Miura, Megan Grant, Richard Marais, Adele Green
Author Information
  1. Tricia Tay: Royal Lancaster Infirmary, University of Lancaster, UK.
  2. Martin G Cook: Molecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Macclesfield SK10 4TG, UK; Royal Surrey NHS Foundation Trust, Guildford, UK.
  3. Kyoko Miura: Population Studies Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia.
  4. Megan Grant: Molecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Macclesfield SK10 4TG, UK. megan.grant@manchester.ac.uk.
  5. Richard Marais: Molecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Macclesfield SK10 4TG, UK.
  6. Adele Green: Molecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Macclesfield SK10 4TG, UK; Population Studies Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Abstract

No abstract text available.

References

  1. J Eur Acad Dermatol Venereol. 2019 Oct;33(10):1899-1906 [PMID: 31237040]
  2. Cancer. 2010 Sep 1;116(17):4130-8 [PMID: 20564101]
  3. J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1290-1298 [PMID: 33544941]
  4. Ann Surg Oncol. 2005 Mar;12(3):207-13 [PMID: 15827812]
  5. Ann Surg. 2010 Dec;252(6):1052-7 [PMID: 21107116]

MeSH Term

Humans
Melanoma
Skin Neoplasms

Word Cloud

Created with Highcharts 10.0.0ChangingEpidemiologyDesmoplasticMelanoma

Similar Articles

Cited By